Drug intelligence / Profile preview

MAJEE MAX-D

Development stage: Unknown
Lead developer: Pepco
Administration: Oral

Overview

MAJEE MAX-D is a veterinary feed premix and performance enhancer developed by Pepco Pharma. It is intended for oral administration in poultry, dairy, and livestock to provide nutritional support and improve animal performance. As a feed additive, it is marketed to optimize growth and productivity in agricultural settings. The specific composition and molecular mechanism of action are not publicly detailed, as the product is categorized under animal nutrition rather than pharmaceutical R&D.

Brand names: MAJEE MAX-D

Beyond the preview

Go deeper on MAJEE MAX-D.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MAJEE MAX-D.

Explore the full profile